SFDA-2023-0017-V417
Minor variation for application SFDA-2023-0017. Minor variation: Specification Change for Lecanemabix — major revision
Variation Number
SFDA-2023-0017-V417
Type
Minor
Application
Change
Status
Overdue
Fee
€973
Submitted
2023-10-19
Approved
—
Description
Minor variation: Specification Change for Lecanemabix — major revision